In one international study, investigators from Penn are exploring the best way to screen male carriers with increased prostate cancer risk. (pennmedicine.org)
«Based on our findings, physicians should still be watching for prostate cancer risk factors — such as being over the age of 40, having African - American ancestry, or having a family history of the disease — in men taking testosterone therapy, but should not hesitate to prescribe it to appropriate patients for fear of increasing prostate cancer risk,» says lead study investigator and NYU Langone urologist Stacy Loeb, MD, MSc. (sciencedaily.com)
From the SELECT trial vitamin E was associated with increase prostate cancer risk. (nutritionfacts.org)